Literature DB >> 21261219

Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review.

Alexandra Burton1, Stamatina Marougka, Stefan Priebe.   

Abstract

AIM: To identify whether financial or material incentives improve treatment adherence in people with severe mental illness.
METHOD: A systematic review of studies published between 1950 and 2008 was conducted. EMBASE, MEDLINE, EBM, AMED and PsycINFO were searched. Studies were included if a financial or material incentive was offered and if the sample had a severe mental illness.
RESULTS: Fourteen articles were identified; three studies on adherence to psychiatric treatment and one on physical exercise. Ten articles used incentives for adherence to substance misuse treatment programmes. In all studies, financial incentives were associated with an increase in adherence; however the effect was not always maintained once the incentive was withdrawn.
CONCLUSION: While existing research suggests that financial incentives may improve treatment adherence in severely mentally ill populations, very few studies focus on psychiatric treatment. Further research may address the long term effectiveness of incentives on adherence in this population.

Entities:  

Mesh:

Year:  2010        PMID: 21261219

Source DB:  PubMed          Journal:  Epidemiol Psichiatr Soc        ISSN: 1121-189X


  11 in total

Review 1.  Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness.

Authors:  Jennifer W Tidey
Journal:  Prev Med       Date:  2011-12-09       Impact factor: 4.018

2.  Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review.

Authors:  Nathan Hodson; Madiha Majid; Ivo Vlaev; Swaran Preet Singh
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

3.  Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study.

Authors:  Stefan Priebe; Julia Sinclair; Alexandra Burton; Stamatina Marougka; John Larsen; Mike Firn; Richard Ashcroft
Journal:  J Med Ethics       Date:  2010-06-27       Impact factor: 2.903

Review 4.  Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies.

Authors:  Katrina Witt; Richard van Dorn; Seena Fazel
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Clinician and service user perceptions of implementing contingency management: a focus group study.

Authors:  J M A Sinclair; A Burton; R Ashcroft; S Priebe
Journal:  Drug Alcohol Depend       Date:  2011-06-15       Impact factor: 4.492

Review 6.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

Review 7.  Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Authors:  Rebecca Ryan; Nancy Santesso; Dianne Lowe; Sophie Hill; Jeremy Grimshaw; Megan Prictor; Caroline Kaufman; Genevieve Cowie; Michael Taylor
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

8.  Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.

Authors:  Catherine Henderson; Martin Knapp; Ksenija Yeeles; Stephen Bremner; Sandra Eldridge; Anthony S David; Nicola O'Connell; Tom Burns; Stefan Priebe
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

9.  Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.

Authors:  Stefan Priebe; Ksenija Yeeles; Stephen Bremner; Christoph Lauber; Sandra Eldridge; Deborah Ashby; Anthony S David; Nicola O'Connell; Alexandra Forrest; Tom Burns
Journal:  BMJ       Date:  2013-10-07

10.  Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial.

Authors:  Stefan Priebe; Stephen A Bremner; Hana Pavlickova
Journal:  BMJ Open       Date:  2016-09-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.